India, Jan. 16 -- Kyocera Corp. (KYO), a Japanese manufacturer of medical products, announced Wednesday that its U.S. unit Kyocera International, Inc., has finalized an agreement to buy certain assets from Renovis Surgical Technologies, Inc., a U.S.-based orthopedic and spinal medical device manufacturer and developer. The financial terms of the deal were not disclosed.
The purchasing assets include Renovis' business operations relating to artificial joint and spinal products. The assets will be transferred into a new California-based company wholly owned by Kyocera International to be named Kyocera Medical Technologies, Inc., in March 2019.
Kyocera said it currently manufactures medical products, including artificial joints and dental im...